SCHEMBL3926095

SCHEMBL3926095

CC(=O)S(=O)(=O)NO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13219515 0.76
SCHEMBL28910894 0.71 CA2 (0.36)
SCHEMBL3667306 0.71
SCHEMBL28225156 0.71 KDM4E (0.37)
SCHEMBL27551517 0.71
SCHEMBL28602292 0.67 CRBN (0.39)
Ethylene SCHEMBL27432797 0.67 DHFR (0.34)
SCHEMBL570625 0.62
SCHEMBL8229531 0.62
SCHEMBL8706722 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035042-A2 METALLO-HYDROLASE INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES Viamet Pharmaceuticals, Inc. (US) 2009-03-18 EP disclosed
WO-2008036445-A2 METALLO-HYDROLASE INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES VIAMET PHARMACEUTICALS, INC. (US) 2008-03-27 WO disclosed